APA (7th ed.) Citation

DM, S., D, I., CL, F., UA, Y., M, B., LJ, B., . . . MA, L. (2017). Constitutive activation of alternative nuclear factor kappa B pathway in canine diffuse large B-cell lymphoma contributes to tumor cell survival and is a target of new adjuvant therapies. Leukemia & lymphoma, 58(7), 1702. https://doi.org/10.1080/10428194.2016.1260122

Chicago Style (17th ed.) Citation

DM, Seelig, et al. "Constitutive Activation of Alternative Nuclear Factor Kappa B Pathway in Canine Diffuse Large B-cell Lymphoma Contributes to Tumor Cell Survival and Is a Target of New Adjuvant Therapies." Leukemia & Lymphoma 58, no. 7 (2017): 1702. https://doi.org/10.1080/10428194.2016.1260122.

MLA (9th ed.) Citation

DM, Seelig, et al. "Constitutive Activation of Alternative Nuclear Factor Kappa B Pathway in Canine Diffuse Large B-cell Lymphoma Contributes to Tumor Cell Survival and Is a Target of New Adjuvant Therapies." Leukemia & Lymphoma, vol. 58, no. 7, 2017, p. 1702, https://doi.org/10.1080/10428194.2016.1260122.